Drug Firm Shares in Slump  NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck  #38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.